Furthermore, generating high levels of soluble endoglin in the tumor microenvironment might impact the bio-availability of free BMP-9, which can act on the endothelial cells and regulating angiogenesis, cancer-associated fibroblasts and potential regulatory T cells and macrophages (25, 28). The gene discussed is GDF2; the disease is neoplasm.